Youri Glupczynski

Youri Glupczynski's AcademicInfluence.com Rankings

Youri Glupczynski

Biology

#13416

World Rank

#16961

Historical Rank

Biotechnology

#248

World Rank

#250

Historical Rank

Microbiology

#826

World Rank

#908

Historical Rank

Molecular Biology

#2265

World Rank

#2299

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Youri Glupczynski Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Youri Glupczynski's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Aminoglycosides: Activity and Resistance (1999) (979)
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption (2012) (815)
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. (2012) (796)
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. (2007) (595)
EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance (2012) (422)
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. (2017) (407)
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread (2019) (359)
Serologic detection of infection with cagA+ Helicobacter pylori strains (1995) (318)
Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. (2013) (257)
The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. (1997) (233)
Metronidazole resistance in Helicobacter pylori (1990) (217)
Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. (2003) (213)
Diagnosis of Helicobacter pylori infection by PCR: comparison with other invasive techniques and detection of cagA gene in gastric biopsy specimens (1995) (191)
Drug therapy for Helicobacter pylori infection: problems and pitfalls. (1990) (163)
Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). (2012) (157)
TREATMENT FAILURE OF OFLOXACIN IN CAMPYLOBACTER PYLORI INFECTION (1987) (157)
Accurate Prediction of Macrolide Resistance in Helicobacter pylori by a PCR Line Probe Assay for Detection of Mutations in the 23S rRNA Gene: Multicenter Validation Study (2001) (153)
Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori (1991) (152)
Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. (2005) (145)
Evaluation of a DNA Microarray (Check-MDR CT102) for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum β-Lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 Carbapenemases (2011) (144)
Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Nocardia Species (2010) (139)
Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin. (1988) (127)
Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals. (2012) (126)
Emergence of ArmA and RmtB aminoglycoside resistance 16S rRNA methylases in Belgium. (2007) (126)
Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium. (2006) (124)
Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? (2001) (121)
Comparable High Rates of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli in Birds of Prey from Germany and Mongolia (2012) (115)
Prevalence and Mechanisms of Resistance to Fluoroquinolones in Helicobacter pylori Strains from Patients Living in Belgium (2006) (109)
Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. (1997) (106)
Validation of carbapenemase and extended-spectrum β-lactamase multiplex endpoint PCR assays according to ISO 15189. (2013) (105)
Serum N-glycan profile shift during human ageing (2010) (105)
European Multicentre Survey of in Vitro Antimicrobial Resistance in Helicobacter pylori (2001) (103)
Efficient Detection of Carbapenemase Activity in Enterobacteriaceae by Matrix-Assisted Laser Desorption Ionization−Time of Flight Mass Spectrometry in Less Than 30 Minutes (2015) (103)
Comparison of the E Test and Agar Dilution Method for Antimicrobial Suceptibility Testing of Helicobacter pylori (2002) (101)
Antimicrobial Resistance in Invasive Non-typhoid Salmonella from the Democratic Republic of the Congo: Emergence of Decreased Fluoroquinolone Susceptibility and Extended-spectrum Beta Lactamases (2013) (100)
Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest. (2006) (99)
Rapid emergence of carbapenemase-producing Enterobacteriaceae isolates in Belgium. (2011) (99)
A combined phenotypic and genotypic method for the detection of Mex efflux pumps in Pseudomonas aeruginosa. (2007) (96)
Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community (2021) (93)
GES Extended-Spectrum β-Lactamases in Acinetobacter baumannii Isolates in Belgium (2010) (93)
A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. (2006) (89)
Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers. (2014) (88)
Plasmid-Encoded Carbapenem-Hydrolyzing β-Lactamase OXA-48 in an Imipenem-Susceptible Klebsiella pneumoniae Strain from Belgium (2008) (83)
Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria (2006) (82)
In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy. (2010) (82)
Detection of Helicobacter pylori infection in children with a standardized and simplified 13C-urea breath test. (1998) (81)
Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria (1986) (80)
National Epidemiologic Surveys ofEnterobacter aerogenes in Belgian Hospitals from 1996 to 1998 (2001) (79)
Reducing time to identification of positive blood cultures with MALDI-TOF MS analysis after a 5-h subculture (2015) (79)
Detection and characterization of class A extended-spectrum-beta-lactamase-producing Pseudomonas aeruginosa isolates in Belgian hospitals. (2010) (78)
Evaluation of two new commercial immunochromatographic assays for the rapid detection of OXA-48 and KPC carbapenemases from cultured bacteria. (2016) (77)
Evaluation of a New Selective Chromogenic Agar Medium for Detection of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae (2006) (77)
Emergence of NDM-1-Producing Enterobacteriaceae in Belgium (2011) (75)
Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures (2016) (74)
The reliability of urease tests, histology and culture in the diagnosis of Campylobacter pylori infection. (1989) (74)
In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents (1988) (72)
Trends in production of extended-spectrum beta-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. (2011) (72)
Evaluation of a commercially available second-generation immunoglobulin G enzyme immunoassay for detection of Helicobacter pylori infection (1992) (70)
Antimicrobial resistance in Helicobacter pylori: a global overview. (1998) (70)
Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. (2007) (69)
Epidemiological investigation of a nosocomial outbreak of multidrug-resistant Corynebacterium striatum at one Belgian university hospital. (2014) (68)
Evaluation of Brilliance ESBL Agar, a Novel Chromogenic Medium for Detection of Extended-Spectrum-Beta- Lactamase-Producing Enterobacteriaceae (2010) (67)
Outbreak of Infection by Carbapenem-Resistant Acinetobacter baumannii Producing the Carbapenemase OXA-58 in Belgium (2006) (66)
Evaluation of Oxoid combination discs for detection of extended-spectrum beta-lactamases. (2003) (66)
Epidemiology of Multidrug-Resistant Microorganisms among Nursing Home Residents in Belgium (2013) (64)
Evaluation of the Xpert MRSA assay for rapid detection of methicillin-resistant Staphylococcus aureus from nares swabs of geriatric hospitalized patients and failure to detect a specific SCCmec type IV variant (2010) (63)
Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993. (1995) (62)
Evaluation of various multi-drug eradication regimens for Helicobacter pylori (1992) (60)
Rapid detection and discrimination of chromosome- and MCR-plasmid-mediated resistance to polymyxins by MALDI-TOF MS in Escherichia coli: the MALDIxin test (2018) (60)
OXA-198, an Acquired Carbapenem-Hydrolyzing Class D β-Lactamase from Pseudomonas aeruginosa (2011) (60)
Prospective evaluation of the OKN K-SeT assay, a new multiplex immunochromatographic test for the rapid detection of OXA-48-like, KPC and NDM carbapenemases (2017) (56)
Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori. (2002) (56)
In vivo deletion of the methicillin resistance mec region from the chromosome of Staphylococcus aureus strains. (2000) (55)
Accuracy of serology and 13C-urea breath test for detection of Helicobacter pylori in children. (1999) (54)
Multicenter Evaluation of a New DNA Microarray for Rapid Detection of Clinically Relevant bla Genes from β-Lactam-Resistant Gram-Negative Bacteria (2011) (53)
Evaluation of the BYG Carba Test, a New Electrochemical Assay for Rapid Laboratory Detection of Carbapenemase-Producing Enterobacteriaceae (2015) (51)
Evaluation of a New Phenotypic OXA-48 Disk Test for Differentiation of OXA-48 Carbapenemase-Producing Enterobacteriaceae Clinical Isolates (2015) (47)
Nosocomial infections caused by multidrug-resistant Pseudomonas putida isolates producing VIM-2 and VIM-4 metallo-beta-lactamases. (2008) (47)
DISTRIBUTION AND PREVALENCE OF ANTIMICROBIAL RESISTANCE AMONG GRAM-NEGATIVE ISOLATES IN INTENSIVE CARE UNITS (ICU) IN BELGIAN HOSPITALS BETWEEN 1996 AND 1999 (2001) (46)
Activities of Ceftobiprole and Other Cephalosporins against Extracellular and Intracellular (THP-1 Macrophages and Keratinocytes) Forms of Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus (2009) (46)
Evaluation of the ePlex Blood Culture Identification Panels for Detection of Pathogens in Bloodstream Infections (2018) (44)
Comparative Evaluation of Two Chromogenic Tests for Rapid Detection of Carbapenemase in Enterobacteriaceae and in Pseudomonas aeruginosa Isolates (2014) (44)
Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate (2016) (43)
ESBL-Positive Enterobacteria Isolates in Drinking Water (2012) (43)
Pseudomonas paucimobilis peritonitis in patients treated by peritoneal dialysis (1984) (43)
Is procalcitonin a good marker of renal lesion in febrile urinary tract infection? (2005) (42)
Microbiological and serological diagnostic tests for Helicobacter pylori: an overview. (1998) (41)
Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations. (2007) (40)
GES-18, a New Carbapenem-Hydrolyzing GES-Type β-Lactamase from Pseudomonas aeruginosa That Contains Ile80 and Ser170 Residues (2012) (40)
Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint. (2011) (40)
Multicentre evaluation of the Check-Direct CPE® assay for direct screening of carbapenemase-producing Enterobacteriaceae from rectal swabs. (2015) (40)
Implementation of a protocol for administration of vancomycin by continuous infusion: pharmacokinetic, pharmacodynamic and toxicological aspects. (2013) (39)
Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing KPC-2 carbapenemase in Belgium. (2010) (39)
Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Hospital (2011) (38)
Evaluation of the Abbott LCx Mycobacterium tuberculosis Assay for Direct Detection of Mycobacterium tuberculosis Complex in Human Samples (1999) (37)
Comparative Evaluation of Four Phenotypic Tests for Detection of Carbapenemase-Producing Gram-Negative Bacteria (2016) (37)
In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care units (2007) (36)
Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center (2016) (36)
Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015 (2017) (35)
Role of Acidic pH in the Susceptibility of Intraphagocytic Methicillin-Resistant Staphylococcus aureus Strains to Meropenem and Cloxacillin (2007) (34)
Analytical validation of a novel high multiplexing real-time PCR array for the identification of key pathogens causative of bacterial ventilator-associated pneumonia and their associated resistance genes. (2013) (34)
Effect of antibiotics carry-over on bacterial counting by 'spiral plating'. (1988) (34)
Characterization of ESBL- and AmpC-Producing Enterobacteriaceae from Diseased Companion Animals in Europe. (2015) (33)
Carbapenem-Resistant Acinetobacter baumannii Isolates Expressing the blaOXA-23 Gene Associated with ISAba4 in Belgium (2008) (33)
Rapid colorimetric hybridization assay for detecting amplified Helicobacter pylori DNA in gastric biopsy specimens (1996) (33)
Failure of azythromycin to eradicate Campylobacter pylori from the stomach because of acquired resistance during treatment. (1990) (32)
Eradicating Helicobacter pylori (1992) (32)
Antimicrobial susceptibility of anaerobic bacteria in Belgium as determined by E-test methodology (2009) (31)
Kinetic and Crystallographic Studies of Extended-Spectrum GES-11, GES-12, and GES-14 β-Lactamases (2012) (31)
Restoration of Susceptibility of Intracellular Methicillin-Resistant Staphylococcus aureus to β-Lactams: Comparison of Strains, Cells, and Antibiotics (2008) (31)
Replicon typing characterization of plasmids encoding resistance to gentamicin and apramycin in Escherichia coli and Salmonella typhimurium isolated from human and animal sources in Belgium (1993) (31)
Gardnerella vaginalis bacteremia from pulmonary abscess in a male alcohol abuser (1989) (31)
Multidrug-resistant bacteria colonization amongst patients newly admitted to a geriatric unit: a prospective cohort study. (2012) (31)
Emergence and Dissemination of BEL-1-Producing Pseudomonas aeruginosa Isolates in Belgium (2007) (30)
Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium. (2013) (30)
Antimicrobial Resistance Testing of Verocytotoxin-Producing Escherichia coli and First Description of TEM-52 Extended-Spectrum β-Lactamase in Serogroup O26 (2010) (30)
Evaluation of a DNA microarray for rapid detection of the most prevalent extended-spectrum β-lactamases, plasmid-mediated cephalosporinases and carbapenemases in Enterobacteriaceae, Pseudomonas and Acinetobacter. (2016) (29)
Emergence of Enterobacter aerogenes as a major antibiotic-resistant nosocomial pathogen in Belgian hospitals. (1999) (28)
Prediction of Lyme Meningitis Based on a Logistic Regression Model Using Clinical and Cerebrospinal Fluid Analysis: A European Study (2009) (27)
Emergence of NDM-1-producing Acinetobacter baumannii in Belgium. (2012) (27)
IMP-13-producing Pseudomonas monteilii recovered in a hospital environment. (2011) (26)
Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015 (2019) (26)
Increasing incidence of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Belgian hospitals (2016) (26)
Septicemia due to Solobacterium moorei in a patient with multiple myeloma. (2006) (26)
Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia (2015) (25)
Surveillance of Helicobacter pylori Resistance to Antibiotics in Europe 2008-2009 (2011) (25)
Optimization of the MALDIxin test for the rapid identification of colistin resistance in Klebsiella pneumoniae using MALDI-TOF MS (2019) (25)
On: The who's and when's of therapy for Helicobacter pylori. (1991) (25)
Evaluation of a commercially available complement fixation test for diagnosis of Helicobacter pylori infection and for follow-up after antimicrobial therapy (1992) (25)
Campylobacter and helicobacter infections (1992) (25)
Could Acinetobacter pittii act as an NDM-1 reservoir for Enterobacteriaceae? (2013) (24)
Rapid Identification of OXA-48 and OXA-163 Subfamilies in Carbapenem-Resistant Gram-Negative Bacilli with a Novel Immunochromatographic Lateral Flow Assay (2016) (24)
Probe ligation and real-time detection of KPC, OXA-48, VIM, IMP, and NDM carbapenemase genes. (2013) (23)
Susceptibility of clinical isolates of campylobacter pylori to 24 antimicrobial and anti-ulcer agents (1988) (23)
Pseudo-Outbreak of Extremely Drug-Resistant Pseudomonas aeruginosa Urinary Tract Infections Due to Contamination of an Automated Urine Analyzer (2012) (23)
Comparison of tests for assessment of Helicobacter pylori eradication: results of a multi‐centre study using centralized facility testing (2000) (23)
Presence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in waste waters, Kinshasa, the Democratic Republic of the Congo (2012) (23)
Prevalence of Helicobacter pylori in rural Kivu, eastern Zaire: A prospective endoscopic study (1991) (21)
Emergence and dissemination of multidrug resistant clones of Pseudomonas aeruginosa producing VIM-2 metallo-beta-lactamase in Belgium. (2007) (21)
Genetic and Biochemical Characterization of OXA-519, a Novel OXA-48-Like β-Lactamase (2018) (21)
OXA‐427, a new plasmid‐borne carbapenem‐hydrolysing class D &bgr;‐lactamase in Enterobacteriaceae (2017) (20)
In vitro susceptibility testing of Helicobacter pylori to antimicrobial agents: basis for treatment or microbiologists' obsession? (1993) (20)
Multicentre evaluation of the BYG Carba v2.0 test, a simplified electrochemical assay for the rapid laboratory detection of carbapenemase-producing Enterobacteriaceae (2017) (20)
The diagnosis of Helicobacter pylori infection: a microbiologist's perspective (1994) (20)
Molecular Characterization of OXA-198 Carbapenemase-Producing Pseudomonas aeruginosa Clinical Isolates (2018) (20)
Optimal assessment of the ability of children with recurrent respiratory tract infections to produce anti‐polysaccharide antibodies (2007) (20)
Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes. (2010) (20)
A multicentre survey of antimicrobial resistance in gram-negative isolates from Belgian intensive care units in 1994-1995. Belgian Multicenter ICU Study Group. (1998) (19)
Genetic Structure Associated with blaOXA-18, Encoding a Clavulanic Acid-Inhibited Extended-Spectrum Oxacillinase (2008) (19)
Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered at two Belgian hospitals. (2010) (19)
Plesiomonas shigelloides septicemia in a patient with primary hemochromatosis. (1995) (19)
Transcriptomic biomarkers of human ageing in peripheral blood mononuclear cell total RNA (2010) (19)
Microbiological and serological diagnostic tests for Helicobacter pylori: an overview. (1998) (18)
137 – Mechanisms of Action (2010) (18)
Correlation between cytotoxicity induced by Pseudomonas aeruginosa clinical isolates from acute infections and IL-1β secretion in a model of human THP-1 monocytes. (2015) (17)
Effect of the vacuolating toxin from Helicobacter pylori in the pathogenesis of duodenal and peptic ulcer (1992) (17)
Global spread of New Delhi metallo-β-lactamase 1. (2010) (17)
In-vitro activity of pefloxacin compared to other antibiotics. (1986) (17)
Spread of Plasmids Carrying Multiple GES Variants (2016) (16)
Asymptomatic Colonization by Clostridium difficile in Older Adults Admitted to a Geriatric Unit: A Prospective Cohort Study (2011) (16)
Serology in Helicobacter pylori infection. (1993) (16)
Use of a urea breath test versus invasive methods to determine the prevalence ofHelicobacter pylori in zaire (1992) (16)
Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study (2017) (16)
Enteroaggregative Shiga toxin-producing Escherichia coli of serotype O104:H4 in Belgium and Luxembourg (2014) (16)
Campylobacter pylori-associated gastritis: attempts to eradicate the bacteria by various antibiotics and anti-ulcer regimens. (1988) (15)
Group IVc-2-associated peritonitis (1985) (15)
In-vitro activity of lomefloxacin in comparison with pefloxacin and ofloxacin. (1989) (15)
Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin. (1988) (14)
In Vitro Susceptibility of Helicobacter pylori to Antibiotics and Bismuth Salts and the Importance of Acquired Resistance to Antibiotics in Treatment Failures of H. pylori Infection (1990) (14)
Evaluation of several phenotypic methods for the detection of carbapenemase-producing Pseudomonas aeruginosa (2015) (14)
In vitro susceptibility of multidrug-resistant Enterobacteriaceae clinical isolates to tigecycline. (2012) (14)
Detection and Characterization of VIM-31, a New Variant of VIM-2 with Tyr224His and His252Arg Mutations, in a Clinical Isolate of Enterobacter cloacae (2012) (14)
In-vitro activity of two new carbapenems FCE 22101 and CGP 31608 in comparison with imipenem. (1987) (13)
Phenotypic and Molecular Characterisations of Carbapenem-resistant Acinetobacter baumannii Isolates Collected within the EURECA Study. (2021) (13)
Evaluation of the RESIST-4 K-SeT assay, a multiplex immunochromatographic assay for the rapid detection of OXA-48-like, KPC, VIM and NDM carbapenemases (2019) (13)
ECTHYMA GANGRENOSUM IN A NONNEUTROPAENIC, ELDERLY PATIENT: CASE REPORT AND REVIEW OF THE LITERATURE (2008) (13)
The three‐dimensional structure of VIM‐31 – a metallo‐β‐lactamase from Enterobacter cloacae in its native and oxidized form (2015) (13)
Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis. (1991) (13)
Lack of antibiotic compliance in patients treated for Campylobacter pylori-associated gastritis. (1989) (12)
An Outpatient Clinic as a Potential Site of Transmission for an Outbreak of New Delhi Metallo-&bgr;-Lactamase–producing Klebsiella pneumoniae Sequence Type 716: A Study Using Whole-genome Sequencing (2018) (12)
Correlation between growth curve and killing curve of Escherichia coli after a brief exposure to suprainhibitory concentrations of ampicillin and piperacillin (1985) (12)
Nosocomial outbreak of extended-spectrum β-lactamase-producing Enterobacter cloacae among cardiothoracic surgical patients: causes and consequences. (2019) (12)
Clinical Evaluation ofTeicoplanin forTherapy ofSevere Infections Caused byGram-Positive Bacteria (1986) (12)
Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals. (2009) (12)
Lyme neuroborreliosis in children (2010) (12)
Evaluation of a new meropenem-EDTA double-ended Etest strip for the detection of the cfiA metallo-beta-lactamase gene in clinical isolates of Bacteroides fragilis. (2008) (12)
A single Proteus mirabilis lineage from human and animal sources: a hidden reservoir of OXA-23 or OXA-58 carbapenemases in Enterobacterales (2020) (12)
Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium. (2012) (11)
Rate of bactericidal activity for Branhamella catarrhalis of a new macrolide, CP-62,993, compared with that of amoxicillin-clavulanic acid. (1988) (11)
Effect of antimicrobial therapy on the specific serological response toHelicobacter pylori infection (1992) (11)
Surveillance of pneumococcal resistance in Belgium during winter 1996-1997. (1998) (11)
In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin. (1996) (11)
Bactericidal activity of meropenem against Pseudomonas aeruginosa. (1989) (11)
Clinical case of cfr-positive MRSA CC398 in Belgium (2017) (10)
COMPARATIVE IN VITRO ACTIVITY OF TEMOCILLIN AND OTHER ANTIMICROBIAL AGENTS AGAINST ENTEROBACTERIACEAE ISOLATED FROM PATIENTS ADMITTED TO FIVE BELGIAN HOSPITALS (2001) (10)
Mycobacterial cross-contamination of bronchoscopy specimens. (1988) (10)
USEFULNESS OF BACTERIOLOGICAL SURVEILLANCE CULTURES FOR MONITORING INFECTION IN HOSPITALIZED PATIENTS: A CRITICAL REAPPRAISAL (2001) (10)
Prolonged gastric acid suppression therapy: a significant risk factor for Listeria monocytogenes infection? (1996) (10)
Evaluation of the βLACTA Test, a Novel Commercial Chromogenic Test for Rapid Detection of Ceftazidime-Nonsusceptible Pseudomonas aeruginosa Isolates (2013) (10)
Isolation ofMobiluncus in four cases of extragenital infections in adult women (1984) (10)
Evaluation of avibactam-supplemented combination disk tests for the detection of OXA-48 carbapenemase-producing Enterobacteriaceae. (2014) (10)
Effect on growth curve patterns of brief exposure of bacteria to different concentrations of beta-lactam antibiotics. (1985) (10)
Evaluation of the OXA-23 K-SeT® immunochromatographic assay for the rapid detection of OXA-23-like carbapenemase-producing Acinetobacter spp (2019) (9)
Design and validation of a low density array (Nosochip) for the detection and identification of the main pathogenic bacteria and fungi responsible for nosocomial pneumonia (2007) (9)
Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium. (2011) (9)
STAPHYLOCCOCAL SCALDED SKIN SYNDROME IN AN ADULT (2004) (9)
Infection due to travel-related carbapenemase-producing Enterobacteriaceae, a largely underestimated phenomenon in Belgium (2015) (9)
EXTERNAL VALIDATION OF THE BACTERIAL MENINGITIS SCORE IN CHILDREN HOSPITALIZED WITH MENINGITIS (2012) (9)
AZTREONAM IN CAPD PERITONITIS (1987) (9)
In vitro activity of amoxycillin plus clavulanic acid and ticarcillin plus clavulanic acid compared with that of other antibiotics against anaerobic bacteria. (1989) (8)
About three cases of ulceroglandular tularemia, is this the re-emergence of Francisella tularensis in Belgium? (2015) (8)
Health outcomes of older patients colonized by multi-drug resistant bacteria (MDRB): a one-year follow-up study. (2013) (8)
Improvement of identification of Capnocytophaga canimorsus by matrix-assisted laser desorption ionization-time of flight mass spectrometry using enriched database. (2016) (8)
Delayed diagnosis of meningitis caused by beta-haemolytic group G. Streptococcus in an older woman. (2001) (8)
Bactericidal effect and regrowth of Streptococcus faecalis exposed to amoxicillin following beta-lactamase. (1988) (8)
Evaluation of the Novodiag CarbaR+, a Novel Integrated Sample to Result Platform for the Multiplex Qualitative Detection of Carbapenem and Colistin Resistance Markers. (2020) (8)
SURVEILLANCE OF ANTIBIOTIC RESISTANCE IN NON INVASIVE CLINICAL ISOLATES OF STREPTOCOCCUS PNEUMONIAE COLLECTED IN BELGIUM DURING WINTERS 2003 AND 2004. (2006) (8)
Detection of a VIM-27-Producing Klebsiella pneumoniae Isolate in a Patient following Surgical Tourism in Greece (2011) (8)
Infection de prothese de hanche a Yersinia enterocolitica (1989) (7)
10th survey of antimicrobial resistance in noninvasive clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2007-2008. (2010) (7)
Performance of different culture methods and of a commercial molecular assay for the detection of carbapenemase-producing Enterobacteriaceae in nursing homes and rehabilitation centers (2015) (7)
Prospective evaluation of a high multiplexing real-time polymerase chain reaction array for the rapid identification and characterization of bacteria causative of nosocomial pneumonia from clinical specimens: a proof-of-concept study (2017) (7)
Shigella flexneri bacteraemia in a patient with acquired immune deficiency syndrome. (1985) (7)
Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum beta-lactamase associated with the ST131 Escherichia coli clone in Belgium. (2010) (7)
VERTEBRAL OSTEOMYELITIS WITH SPINAL EPIDURAL ABSCESS IN TWO PATIENTS WITH BACTEROIDES FRAGILIS BACTERAEMIA (2008) (7)
Kingella kingae septicaemia. (1987) (7)
The role of excess iron in the pathogenesis of disturbed neutrophil functions in cirrhotic patients (neutrophil functions in cirrhotic patients). (1987) (7)
Nosocomial pneumonia: diagnosis, epidemiology and treatment. (1999) (7)
Methodological lessons learned from a multicenter trial of Helicobacter pylori infection using centralised laboratory facilities (1997) (6)
Evaluation of random and repetitive motif primed polymerase chain reaction typing of Helicobacter pylori (1995) (6)
Infective endocarditis due to Actinobacillus actinomycetemcomitans. (1984) (6)
Empyema due to Salmonella dublin. (1986) (6)
Fatty acid composition of Streptococcus milleri. (1985) (6)
Correction: Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures (2016) (6)
In vitro activity of amoxycillin/clavulanate and ticarcillin/clavulanate compared with that of other antibiotics against anaerobic bacteria: comparison with the results of the 1987 survey. (1996) (6)
SURVEILLANCE OF ANTIBIOTIC RESISTANCE IN CLINICAL ISOLATES OF STREPTOCOCCUS PNEUMONIAE COLLECTED IN BELGIUM DURING WINTER 2000-2001 (2003) (6)
A recurrent and transesophageal echocardiography–associated outbreak of extended-spectrum β-lactamase–producing Enterobacter cloacae complex in cardiac surgery patients (2019) (6)
Emergence of Panton-Valentine leukocidin positive community-acquired MRSA infections in Belgium (2004) (6)
Streptococcus pneumoniae clinical isolate highly resistant to fluoroquinolones in a child. (2006) (6)
Role of gastric mucosal cytokines in the immunopathogenesis of Helicobacter pylori infection: new hypotheses but still few certitudes (1997) (6)
In Vitro Study on the Antimicrobial Activity of Various Antibiotics Against Clinical Isolates Of Streptococcus Pneumoniae From Belgium Collected During Winter 1998-1999 (2000) (5)
EFFECT OF A 5‐YEAR MULTIDISCIPLINARY COLLABORATIVE PROGRAM ON ANTIBIOTIC CONSUMPTION IN AN ACUTE GERIATRIC WARD (2007) (5)
[Clinical, endoscopic and histologic findings in 1,100 patients of whom 574 were colonized by Campylobacter pylori]. (1989) (5)
Omeprazole exerts the same inhibitory effect on the growth of cytotoxic-positive and cytotoxic-negative Helicobacter pylori strains and does not inhibit vacuolating toxin production (1994) (5)
In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium (2022) (5)
Reversion of resistance in relapsing infection caused by a glycopeptide-intermediate methicillin-resistant Staphylococcus aureus isolate (2007) (5)
Rate of bactericidal activity for Streptococcus faecalis of a new quinolone, CI-934, compared with that of amoxicillin (1986) (5)
Submandibular lymphadenitis caused by Mycobacterium interjectum: contribution of new diagnostic tools (2010) (5)
OXA-48 Producing Klebsiella pneumoniae in a Household Contact of a Previously Infected Patient: Person-to-Person Transmission or Coincidental Community Acquisition? (2016) (4)
Emergence and dissemination of multi-resistant Gram negative Enterobacteriaceae: lessons to be learnt from local and national surveillance programs in Belgium (2015) (4)
Prolonged Survival of an Elderly Woman with Salmonella Dublin Aortitis and Conservative Treatment (2003) (4)
Neutralising antibodies to the vacuolating toxin of Helicobacter pylori in gastritis only and peptic ulcer patients. (1993) (4)
Histological severity of gastritis in H. pylori infected people lacking a systemic antibody response (1992) (4)
[Significance of the presence of Campylobacter pyloridis in the gastric antrum. Results of a prospective study in 212 patients]. (1986) (4)
Protective effect of amdinocillin against emergence of resistance to ceftazidime in Enterobacter cloacae (1988) (4)
Helicobacter pylori and gastric cancer. An endoscopic series. (1997) (4)
Trends in antimicrobial susceptibility among isolates of Campylobacter species isolated from humans in 1996 to 2002 in Belgium (2003) (4)
Intrathoracic lymphadenitis caused by Mycobacterium avium and Mycobacterium tuberculosis in an immunocompetent child. (2008) (4)
Effect on growth curves and killing curves of brief exposure of Escherichia coli to imipenem and piperacillin. (1986) (4)
Helicobacter pylori: The place of the new macrolides in the eardication of the bacteria in peptic ulcer disease (2006) (4)
[Isolation of Vibrio alginolyticus from a leg ulcer]. (1990) (3)
Patterns of antibiotic use, pathogens and clinical outcomes in hospitalised neonates and young infants with sepsis in the NeoOBS global neonatal sepsis observational cohort study (2022) (3)
Prevalence of antibiotic resistance in Helicobacter pylori strains in Poland. (1998) (3)
Multicenter study of automated systems for colistin susceptibility testing (2020) (3)
Abstract form for the Irish Journal of Medical Science v workshop on gastroduodenal pathology and Helicobacter pylori July 5th — 7th 1992 — Dublin, Ireland (1992) (3)
Update on Helicobacter pylori research. Eradication. (1997) (3)
Surveillance of antimicrobial resistant bacteria in Belgian hospitals: Report 2016 (2018) (3)
In vitro susceptibilities of 176 clinical isolates of Streptococcus pneumoniae to 11 beta-lactams, erythromycin, and tetracycline. (1996) (3)
Capsular types and antibiotic sensitivity of pneumococci isolated from patients with serious infections in Belgium 1980 to 1988 (1990) (3)
Effect of mecillinam on Escherichia coli growth curves when given alone and associated with ampicillin. (1986) (2)
Comparative In Vitro Activity of Amphotericine B, Itraconazole, Voriconazole and Posaconazole against Aspergillus fumigatus (2001) (2)
P1006 Imported cases of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in Belgium: characterisation and unusual loss of resistance (2007) (2)
Systemic effects of colchicine on phosphate metabolism in innervated and denervated, slow and fast muscles of the rat. (1980) (2)
The NeoSep Severity and Recovery scores to predict mortality in hospitalized neonates and young infants with sepsis derived from the global NeoOBS observational cohort study (2022) (2)
Analysis from the NeoOBS Global Neonatal Sepsis Prospective Observational Cohort Study Across 19 Hospitals in 11 Countries; Clinical Presentation, Treatment, Mortality Outcomes and Development of the NeoSEP Sepsis Severity Score (2021) (2)
Why Should We Treat Helicobacter pylori Infection (1990) (2)
Susceptibility Testing of Helicobacter pylori (2)
Susceptibility of anaerobic bacteria to Sch 34343 and other antibiotics. (1985) (2)
Diversity in the Characteristics of Klebsiella pneumoniae ST101 of Human, Environmental, and Animal Origin (2022) (2)
Temocillin: comparative in vitro activity against gram-negative clinical isolates. (1988) (2)
Investigation of an outbreak of multiresistant Enterobacter aerogenes infection in an intensive care unit (1997) (2)
Susceptibility of Streptococcus pneumoniae to chloramphenicol and thiamphenicol. (1983) (2)
Clinical and bacteriological evaluation of ceftazidime (GR 20263) as an antipseudomonal drug. (1981) (2)
Acquired Resistance to Antibiotics: An Underestimated Cause of Failure in the Treatment of Helicobacter pylori Infection (1991) (2)
Rate of bactericidal activity for Branhamella catarrhalis of fleroxacin compared with that of amoxycillin-clavulanic acid. (1988) (2)
Characterization of a multidrug-resistant Acinetobacter baumannii strain carrying the bla NDM-1 and bla OXA-23 carbapenemase genes from the Czech Republic (2012) (2)
GDEPIH-GOSPIZ Belgian consensus strategies to control antibiotic-resistant bacteria in hospitals. (1999) (2)
Comparative in vitro activity of augmentin against community and hospital-acquired gram-negative bacteria. (1988) (2)
Belgian multicentre study on the in vitro activity of cefepime against gram-negative bacilli. (1996) (2)
Helicobacter pylori, Campylobacter and other bacterial infections of the gastrointestinal tract (1992) (1)
Characterization of hypervirulent Klebsiella pneumoniae isolates in Belgium (2022) (1)
P703 Comparative activity of moxifioxacin vs. trimethoprim-sulfamethoxazole, cloxacillin, linezolid, clindamycin, and ciprofioxacin against intracellular methicillin-sensitive and community-acquired methicillin-resistant S. aureus (2007) (1)
Belgian collaborative study of the in-vitro susceptibility of the Bacteroides fragilis group (1988) (1)
Antimicrobial activity of cefaclor on Haemophilus influenzae: correlation between growth and killing curves (1986) (1)
[Trends in pneumococcal infections in Belgium from 1986 to 1991]. (1993) (1)
[Stomach ulcers and Helicobacter pylori. Clinical, endoscopic and histological characteristics]. (1996) (1)
Correlation between the growth and killing curves of Escherichia coli in the presence of cefotetan or piperacillin. (1989) (1)
Resistance to amoxicillin/clavulanate in Escherichia coli. (1992) (1)
Fatty acid composition ofStreptococcus milleri (1985) (1)
[Overprescribing of antibiotics outside the hospital]. (1999) (1)
Structural and Biochemical Features of OXA-517: a Carbapenem and Expanded-Spectrum Cephalosporin Hydrolyzing OXA-48 Variant (2023) (1)
P1355 Epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae in Belgium: preliminary results of a national multicentre survey in 2006 (2007) (1)
ASSESSMENT OF A SIMPLE CLINICAL SCORE FOR SCREENING METHICILLIN‐RESISTANT STAPHYLOCOCCUS AUREUS COLONIZATION IN ELDERLY PATIENTS UPON HOSPITAL ADMISSION (2010) (1)
Multicenter in vitro study of the susceptibility of the Bacteroides fragilis group in Belgium. (1986) (1)
National multicenter survey of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Belgian hospitals in 2013 (2013) (1)
223 SURVEILLANCE OF HEUCOBACTER PYLORI RESISTANCE TO ANTIMICROBIAL AGENTS IN BELGIUM FROM 1989 TO 1994 (2006) (1)
In vitro activity of teicoplanin and vancomycin against anaerobes (1984) (1)
Chapter 130 – Mechanisms of action (2010) (1)
Effect of antimicrobial therapy on specific serologic response to Helicobacter pylori infection (1992) (1)
Selection and counting of aerobic gram-negative bacilli in saliva by the spiral system (1987) (1)
Bactericidal activity of LY-163892, a new cephalosporin, against beta-lactamase-producing strains of Haemophilus influenzae compared with amoxicillin-clavulanic acid (1989) (1)
[Growth curves and killing rate of Haemophilus influenzae exposed to amoxicillin, cefaclor and cefotaxime]. (1986) (1)
Activity of cefsulodin against methicillin-resistant Staphylococcus aureus (1985) (1)
POSTOPERATIVE TETANUS (1984) (1)
Confirmation diagnosis of influenza A(H1N1)2009 by Belgian sentinel laboratories during the epidemic phase (2010) (1)
Novel vancomycin resistance gene cluster in Enterococcus faecium ST1486, Belgium, June 2021 (2021) (1)
The first report of the coproduction of CMY-16 and ArmA 16S rRNA methylases in carbapenemase-ESBL producing Escherichia coli isolates (2020) (1)
Health outcomes of patients colonized by multi-drug resistant bacteria: A one-year follow-up study from a geriatric ward (2012) (1)
Corticoid treatment increases the risk of enterobacter aerogenes infection in intensive care unit (1998) (1)
Penicillin and acute streptococcal pharyngitis. (1994) (0)
P2058 Extracellular and intracellular activities of quinupristin-dalfopristin (Synercid) against Staphylococcus aureus, with different resistant phenotypes (MSSA, MRSA, VISA) (2007) (0)
Human fascioliasis (distomatosis) (1984) (0)
Comparative evaluation of the performance of selective media for the detection of carbapenemase-producing Enterobacteriaceae isolates (2012) (0)
Antibiotic Susceptibility and Mechanisms of ß-lactam Resistance Among Clinical Strains of Pseudomonas aeruginosa in Belgium (2008) (0)
Animal model of Helicobacter pylori infection (1990) (0)
title : Evaluation of two new commercial immunochromatographic assays for the rapid detection of OXA-48 and KPC carbapenemases from cultured bacteria First Author : (2016) (0)
Clinical case of cfr-positive MRSA CC398 in Belgium (2017) (0)
In vitro activity of timentin against community and hospital-acquired gram-negative bacterial isolates. (1989) (0)
P501 Screening of ampC β-lactamases producing Escherichia coli in stool samples (2007) (0)
P3.15 Outbreak of Multiresistant Acinetobacter Baumannii After Transfer of Patients from Greece (2006) (0)
Determining the minimum inhibitory concentration of beta-lactam antibiotics for Haemophilus influenzae: a problem. (1987) (0)
Screening of global microbiomes implies ecological boundaries impacting the distribution and dissemination of clinically relevant antimicrobial resistance genes (2022) (0)
Evaluation of a complement fixation test for detection of H. pylori and for follow-up after antimicrobial therapy (1992) (0)
Clinical and microbiological evaluation of aztreonam in the treatment of lower respiratory tract infections caused by gram-negative bacilli (1985) (0)
Neutralization of the Vacuolating Toxin from Helicobacter pylori by Antisera from Patients with Duodenal or Gastric Ulcer (1994) (0)
[Measure by turbidimetry and bactericidal effect of the speed of action of clavulanic acid, amoxicillin and their combinations on a Haemophilus influenzae producer of beta-lactamase]. (1987) (0)
Is rust a growth promoting factor for Legionella pneumophila? (1984) (0)
Discovery of "curved bacilli" in the stomach. (1993) (0)
Is automatic disinfection between each endoscopy mandatory? Société Royale Belge de Gastro-entérologie. (1998) (0)
Presence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in waste waters, Kinshasa, the Democratic Republic of the Congo (2012) (0)
PVII-3 Successive norovirus epidemics in a hospital: learning from experience (2009) (0)
REPORT OF THE NATIONAL EPIDEMIOLOGIC SURVEY OF ENTEROBACTER AEROGENES IN BELGIAN HOSPITALS IN 1996-98 . (2010) (0)
CRYSTAL STRUCTURE OF OXA-427 class D BETA-LACTAMASE (2019) (0)
Acknowledgement to Referees (1998) (0)
Amoxycillin/clavulanate and Haemophilus influenzae. (1994) (0)
Campylobacter pylori nancy, le 16/1/1988 (2008) (0)
Le MALT lymphome gastrique de bas grade associé à une infection parHelicobacter pylori. Le point de vue du clinicien et de l’endoscopiste (1998) (0)
Reducing time to identification of positive blood cultures with MALDI-TOF MS analysis after a 5-h subculture (2014) (0)
Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia (2015) (0)
Typing of **Helicobacter pylori** by means of polymerase chain reaction mediated DNA fingerprinting (1994) (0)
Symposium on campylobacter pylori (1987) (0)
Prospective evaluation of a high multiplexing real-time polymerase chain reaction array for the rapid identification and characterization of bacteria causative of nosocomial pneumonia from clinical specimens: a proof-of-concept study (2017) (0)
Effect of pH on the rate of bactericidal activity of ampicillin againstEscherichia coli strains (1985) (0)
A recurrent and transesophageal echocardiography–associated outbreak of extended-spectrum β-lactamase–producing Enterobacter cloacae complex in cardiac surgery patients (2019) (0)
P1827 Prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals: results of a multicentre survey (2007) (0)
Ser 170 Residues Pseudomonas aeruginosa That Contains-Lactamase from β GES-Type GES-18 , a New Carbapenem-Hydrolyzing (2012) (0)
CLINICAL, VIROLOGICAL AND EPIDEMIOLOGICAL ASSESSMENT OF 2009 INFLUENZA A (H1N1) PANDEMIC IN A BELGIAN UNIVERSITY HOSPITAL (2012) (0)
Chlamydiaceae Disease in Captive Salamanders (2012) (0)
COMBACTE LAB-Net: building a European laboratory network for clinical trials on anti-infectives. (2021) (0)
O439 In vitro activity of temocillin and other antimicrobial agents against extended-spectrum-b -lactamase-producing Enterobacteriaceae isolated from patients hospitalised in Belgian intensive care units (2007) (0)
Rate of bactericidal activity for Streptococcus faecalis of a new cephalosporin, cefpiramide, compared with cefotaxime and amoxicillin (1988) (0)
[Comparison of the growth curves of Escherichia coli and Haemophilus influenzae subjected to ampicillin and amoxicillin]. (1985) (0)
Comparative genomics of carbapenemase-producing Morganella spp (2023) (0)
P1358 Prevalence of Mex-mediated resistance in Pseudomonas aeruginosa isolates from patients with ventilator-associated pneumonia in 4 Belgian hospitals (2007) (0)
Performance of different culture methods and of a commercial molecular assay for the detection of carbapenemase-producing Enterobacteriaceae in nursing homes and rehabilitation centers (2015) (0)
Cross-reactivity of environmental bacteria with fluorescent-antibody conjugates forLegionella pneumophila (1984) (0)
Reduction in the detection time of OXA-48, OXA-163 and KPC carbapenemases performed with a novel immunochromatographic lateral flow assay from 2-hour-old cultures (early cultures) (2017) (0)
Systemic effects of podophyllotoxin on phosphate metabolism in innervated and denervated, slow and fast muscles of the rat. (1980) (0)
Thermally injured and Acinetobacter baumannii colonizations/infections during a five-year period at the Brussels Burn Wound Centre (2012) (0)
Correction of the specific epithet in the combination Campylobacter fennelliae. (1986) (0)
Is there evidence for a CPE reservoir in nursing homes and rehabilitation centers (2014) (0)
Eradicating Helicobacter pylori. (1992) (0)
Enterobacter cloacae His252Arg Mutations, in a Clinical Isolate of New Variant of VIM-2 with Tyr224His and Detection and Characterization of VIM-31, a (2012) (0)
FALSE DIAGNOSIS OF LEGIONELLOSIS (1982) (0)
Evaluation of several phenotypic methods for the detection of carbapenemase-producing Pseudomonas aeruginosa (2015) (0)
Primary low-grade gastric lymphoma of mucosa associated lymphoid tissue andHelicobacter pylori infection. Clinical, endoscopic and therapeutic aspects (1998) (0)
Increasing incidence of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Belgian hospitals (2016) (0)
Multicenter evaluation of the BYG Carba test v2.0, a simplified electrochemical assay for the rapid laboratory detection of carbapenemase-producing Enterobacteriaceae (2017) (0)
[Molecular biology in the diagnosis of infectious diseases]. (1995) (0)
[Extra-intestinal localization of non-typhoid salmonellosis. 10 case reports]. (1985) (0)
In vitro evaluation of the activity of cefadroxil against Haemophilus influenzae by comparison of growth curves and killing curves (1988) (0)
Evaluation of the (cid:1) LACTA Test, a Novel Commercial Chromogenic Test for Rapid Detection of Ceftazidime-Nonsusceptible Pseudomonas aeruginosa Isolates (2013) (0)
P1354 Prevalence of extended-spectrum β-lactamase-producing Enterobacteriacae isolates at two Belgian hospitals: a descriptive study (2007) (0)
Multicentre evaluation of the BYG Carba v2.0 test, a simplified electrochemical assay for the rapid laboratory detection of carbapenemase-producing Enterobacteriaceae (2017) (0)
Animal model of Helicobacter pylori infection. Autor's reply (1990) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Youri Glupczynski?

Youri Glupczynski is affiliated with the following schools:

Youri Glupczynski's Academic­Influence.com Rankings

Why Is Youri Glupczynski Influential?

Youri Glupczynski's Published Works

Published Works

What Schools Are Affiliated With Youri Glupczynski?

Youri Glupczynski's AcademicInfluence.com Rankings